Dengue is caused by the dengue virus (DENVs) infection and clinical manifestations include
dengue fever (DF), dengue hemorrhagic fever (DHF), or dengue shock syndrome (DSS) …

Dengue is one of the most prevalent mosquito-borne diseases in the world, affecting an
estimated 390 million people each year, according to models. For the last two decades …

Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …

Nanomaterials are becoming important tools for vaccine development owing to their tunable
and adaptable nature. Unique properties of nanomaterials afford opportunities to modulate …

Dengue is the most common arboviral disease caused by one of four distinct but closely
related dengue viruses (DENV) and places significant economic and public health burdens …

Approximately 100–400 million people from more than 100 countries in the tropical and
subtropical world are affected by dengue infections. Recent scientific breakthroughs have …

More than a hundred thousand dengue cases are diagnosed in India annually, and about
half of the country's population carries dengue virus-specific antibodies. Dengue propagates …

In some cases, antibodies can enhance virus entry and replication in cells. This
phenomenon is called antibody-dependent infection enhancement (ADE). ADE not only …

Dengue virus is an arthropod-borne virus, transmitted by Aedes aegypti among humans. In
this review, we discussed the epidemiology of dengue hemorrhagic fever (DHF) as well as …

The origins of preexisting SARS-CoV-2 cross-reactive antibodies and their potential impacts
on vaccine efficacy have not been fully clarified. In this study, we demonstrated that S2 was …